Who owns SILENCE THERAPEUTICS PLC?
- Ticker: SLN
- CUSIP Number: 82686q101
Tip: Access positions for across all investors
Analyze quarterly positions in Silence Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Silence Therapeutics stock
Who bought or sold SILENCE THERAPEUTICS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| TCG Crossover Management | 3.0M | $18M | 0% | Dec 2025 |
|
| Siren | 2.9M | $18M | 0% | Dec 2025 |
|
| Redmile Group | 2.2M | $11M | 0% | Sep 2025 |
|
| Lombard Odier Asset Management | 1.8M | $7.1M | 0% | Sep 2025 |
|
| Nantahala Capital Management | 1.5M | $9.4M | 48% | Dec 2025 |
|
| Vivo Capital | 1.1M | $6.7M | 0% | Dec 2025 |
|
| Nextech Invest | 952k | $5.8M | 0% | Dec 2025 |
|
| Ikarian Capital | 866k | $1.7M | -4% | Dec 2025 |
|
| Dr. Jeffrey R. Jay, M.D. | 808k | $4.9M | 100% | Dec 2025 |
|
| 5AM Venture Management | 476k | $2.9M | 0% | Dec 2025 |
|
| Polygon Management | 365k | $2.2M | 100% | Dec 2025 |
|
| Millennium Management | 299k | $1.5M | 50% | Sep 2025 |
|
| SG Americas Securities | 256k | $1.6M | -17% | Dec 2025 |
|
| Boothbay Fund Management | 209k | $1.3M | -25% | Dec 2025 |
|
| UBS Group | 208k | $1.3M | -32% | Dec 2025 |
|
| M28 Capital Management | 185k | $1.1M | 0% | Dec 2025 |
|
| Hsbc Holdings | 173k | $1.1M | 0% | Dec 2025 |
|
| Marshall Wace | 156k | $947k | 87% | Dec 2025 |
|
| Seven Fleet Capital Management | 148k | $897k | 100% | Dec 2025 |
|
| Point72 Asset Management | 114k | $694k | 100% | Dec 2025 |
|
| Opaleye Management | 79k | $480k | 100% | Dec 2025 |
|
| BlackRock | 73k | $445k | 18% | Dec 2025 |
|
| Two Sigma Investments | 63k | $328k | 7% | Sep 2025 |
|
| Quadrature Capital | 54k | $331k | 100% | Dec 2025 |
|
| Two Sigma Advisers | 43k | $221k | 8% | Sep 2025 |
|
| Susquehanna International | 42k | $255k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 35k | $213k | 100% | Dec 2025 |
|
| Geode Capital Management | 30k | $180k | 0% | Dec 2025 |
|
| Jane Street | 29k | $177k | 100% | Dec 2025 |
|
| Raymond James Financial | 25k | $152k | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 24k | $144k | 27% | Dec 2025 |
|
| Citadel Advisors | 22k | $112k | 100% | Sep 2025 |
|
| Virtus Investment Advisers | 20k | $106k | 21% | Sep 2025 |
|
| Goldman Sachs Group | 18k | $110k | -20% | Dec 2025 |
|
| China Universal Asset Management | 14k | $83k | 66% | Dec 2025 |
|
| Rhumbline Advisers | 13k | $79k | 122% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 12k | $73k | 1904% | Dec 2025 |
|
| XTX Topco | 12k | $71k | 100% | Dec 2025 |
|
| GAMMA Investing | 10k | $62k | 2% | Dec 2025 |
|
| Jpmorgan Chase & Co | 7.8k | $40k | 100% | Sep 2025 |
|
| Barclays | 5.1k | $31k | -29% | Dec 2025 |
|
| Simplex Trading | 4.0k | $24k | 513% | Dec 2025 |
|
| Jones Financial Companies, L.L | 2.5k | $15k | 0% | Dec 2025 |
|
| Tower Research Capital | 2.4k | $15k | 0% | Dec 2025 |
|
| Mirae Asset Global Investments | 2.3k | $14k | 26% | Dec 2025 |
|
| Parallel Advisors | 1.3k | $7.9k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 1.1k | $6.1k | -54% | Sep 2025 |
|
| Global Retirement Partners | 1.0k | $6.1k | 100% | Dec 2025 |
|
| Gf Fund Management | 922.00 | $5.6k | -6% | Dec 2025 |
|
| Steward Partners Investment Advisory | 100.00 | $608.000000 | 0% | Dec 2025 |
|
| Rockefeller Capital Management | 45.00 | $274.000500 | 0% | Dec 2025 |
|
| SBI Securities | 28.00 | $169.999200 | -3% | Dec 2025 |
|
| SageView Advisory Group | 11.00 | $66.999900 | 100% | Dec 2025 |
|
| Advisor Group Holdings | 3.00 | $18.000000 | -100% | Dec 2025 |
|
Who sold out of Silence Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Frazier Life Sciences Management | Sep 2025 | 970k | $5.0M |
| Cantor Fitzgerald, L. P. | Sep 2025 | 801k | $4.2M |
| Woodline Partners | Sep 2025 | 63k | $324k |
| Hrt Financial | Sep 2025 | 11k | $56k |
| EHP Funds | Sep 2025 | 11k | $55k |
| Cambridge Investment Research Advisors | Sep 2025 | 10k | $53k |
| Wexford Capital | Sep 2025 | 7.7k | $40k |
| Acadian Asset Management | Sep 2025 | 4.2k | $21k |
| Principal Securities | Sep 2025 | 17.00 | $88.000500 |